Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
TXGDay performance
| TXG | |
|---|---|
| Price | 43.36 |
| Change Pct | 0.02 |
| Change Abs | 0.01 |
| Market Cap | 5.1 billion |
| Eps | -1.92 |
| Pe Ratio | -22.58 |
| Outstanding Shares | 118.2 million |
| Volume | 285826 |
| Avg Volume | 979417 |
| Industry | Health Information Services |
| Sector Name | Health Care |
| Country Short Name | US |
| Announcement Earnings | 2024-02-13 10:59:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
GH
BEAM
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
TXG
Company descriptions
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets;